These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 5452921)

  • 1. [Cellular mechanism of the antiarrhythmic action of propranolol].
    Kwiatkowska B; Czarnecka M; Lewartowski B
    Acta Physiol Pol; 1970; 21(4):441-54. PubMed ID: 5452921
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrophysiological effects of vanilol on isolated papillary muscles of guinea pigs and atrioventricular conduction in rabbits].
    Xiao JG; Li XD; Liu TP
    Zhongguo Yao Li Xue Bao; 1987 Jan; 8(1):40-4. PubMed ID: 2955656
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mode of action of antiarrhythmic drugs (author's transl)].
    Sano T
    Kokyu To Junkan; 1974 Apr; 22(4):321-6. PubMed ID: 4603686
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of propafenone on slow response action potential and the slow inward current of the myocardium].
    Xu YQ; Liu YM; Gao RB; Mei YA; Xu JM
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):138-40. PubMed ID: 2946151
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of racemic propranolol, dextro-propranolol and racemic practolol on the human and canine cardiac transmembrane action potential (beta blockade and the cardiac action potential).
    Coltart DJ; Meldrum SJ
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):188-97. PubMed ID: 4398411
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relation between the changes of cellular electrogenesis and beta-blocking activity of 4 optical isomers of butydrine].
    Musso E; Taccardi B
    Atti Soc Ital Cardiol; 1969 Jan; 2():268-9. PubMed ID: 5406541
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of several new antiarrhythmic agents on atrial contractility.
    Covino BG; Shannon CM
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):185-92. PubMed ID: 5353470
    [No Abstract]   [Full Text] [Related]  

  • 8. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiarrhythmic peptide has no direct cardiac actions.
    Argentieri T; Cantor E; Wiggins JR
    Experientia; 1989 Aug; 45(8):737-8. PubMed ID: 2759204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative mechanisms of antiarrhythmic agents.
    Pamintuan JC; Dreifus LS; Watanabe Y
    Am J Cardiol; 1970 Nov; 26(5):512-9. PubMed ID: 5478839
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrical effects of the new antiarrhythmic compound Bonnecor (AWD 19-166, GS 015) under arrhythmogenic conditions.
    Nilius B
    Pharmazie; 1985 Dec; 40(12):855-6. PubMed ID: 3841602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular electrophysiological effect of terikalant in the dog heart.
    Biliczki P; Acsai K; Virág L; Tálosi L; Jost N; Biliczki A; Papp JG; Varró A
    Eur J Pharmacol; 2005 Mar; 510(3):161-6. PubMed ID: 15763239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic and electrophysiologic properties of UM-272, dimethyl quaternary propranolol, in the canine heart.
    Kniffen FJ; Schuster DP; Lucchesi BR
    J Pharmacol Exp Ther; 1973 Nov; 187(2):260-8. PubMed ID: 4356014
    [No Abstract]   [Full Text] [Related]  

  • 15. [The specificity of action of penbutolol and propranolol and their optical isomers].
    Kaiser J
    Arzneimittelforschung; 1980; 30(3):427-32. PubMed ID: 6104494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epinephrine - potentiated slowing of conduction in Purkinje fibres.
    Reynolds AK; Chiz JF
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):633-45. PubMed ID: 4456496
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of antifibrillatory drugs on electric elementary processes].
    Fleckenstein A
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():77-87. PubMed ID: 4985686
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kinetics of the recovery of sodium channels from the blocking action of antifibrillatory drugs].
    Liebeswar G; Thaler E; Heistracher P
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):392-3. PubMed ID: 4253824
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological study of quaternary trimecaine derivatives].
    Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP; Bukauskas FF
    Farmakol Toksikol; 1983; 46(4):36-40. PubMed ID: 6617835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of cellular electrophysiology in the development of antiarrhythmic agents.
    Spear JF; Moore EN
    Pacing Clin Electrophysiol; 1982 Mar; 5(2):238-50. PubMed ID: 6176964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.